This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
This volume consists largely of reprints of the important papers published since 1944 on the subject of streptomycin and dihydrostreptomycin in tuberculosis. This book has historical as well as practical value. The first section contains reprints of the first announcements of the in vitro bacteriostatic action of streptomycin against Mycobacterium tuberculosis, the first official report of the in vivo suppressive effect of streptomycin in experimental tuberculosis and the first paper reporting the use of streptomycin in clinical tuberculosis.
The second section is devoted to a brief description of the streptomycin-tuberculosis research project of the American Trudeau Society. In section three, certain bacteriologic problems are discussed. In previously unpublished papers, Dr. William Steenken Jr. of Saranac Lake and Dr. Guy P. Youmans of Northwestern University each discuss the question of bacterial resistance to streptomycin. Another paper, by Sadusk and Swift, reprinted from the Journal of Clinical Investigation, discusses clinical aspects of
Streptomycin and Dihydrostreptomycin in Tuberculosis: Reports of Research Including Studies Sponsored by the American Trudeau Society (Medical Section, National Tuberculosis Association). JAMA. 1950;142(7):519–520. doi:10.1001/jama.1950.02910250067034